Your browser doesn't support javascript.
loading
Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
Li, Yuan; Zheng, Ying; Xu, Bing; Cai, Linrui; Feng, Sheng; Liu, Yiming; Zhu, Zhenyi; Yu, Qin; Guo, Hongyan.
Afiliação
  • Li Y; Department of Obstetrics and Gynecology, Peking University Third Hospital, 49 Huayuan North Road, Beijing, 100000, China.
  • Zheng Y; Department of Gynecologic Oncology, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Xu B; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
  • Cai L; Department of Obstetrics and Gynecology, Peking University Third Hospital, 49 Huayuan North Road, Beijing, 100000, China.
  • Feng S; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
  • Liu Y; National Drug Clinical Trial Institute, West China Second University Hospital, Sichuan University, No. 20, Section 3, South Renmin Road, Chengdu, 610000, China.
  • Zhu Z; National Drug Clinical Trial Institution of West China Second Hospital, Chengdu, China.
  • Yu Q; NMPA Key Laboratory for Technical Resarch on Drug Products In Vitro and In Vivo Correlation, Chengdu, China.
  • Guo H; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Clin Pharmacokinet ; 62(12): 1739-1748, 2023 12.
Article em En | MEDLINE | ID: mdl-37838623

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endometriose Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endometriose Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article